Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Albireo Pharma revenue
Albireo Pharma's revenue is $9.8 million.
What is Albireo Pharma's revenue?
- Albireo Pharma's revenue growth from 2016 to 2022 is -64.89%.
- Albireo Pharma has 130 employees, and the revenue per employee ratio is $75,630.
- Albireo Pharma's peak quarterly revenue was $8.2M in 2022(q1).
- Albireo Pharma peak revenue was $28.0M in 2016.
- Albireo Pharma annual revenue for 2021 was 3.7M, 71.94% growth from 2020.
- Albireo Pharma annual revenue for 2022 was 9.8M, 168.34% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Albireo Pharma historical revenue
Albireo Pharma's peak revenue was $28.0M in 2016. The peak quarterly revenue was $8.2M in 2022(q1).
Albireo Pharma's revenue increased from $28.0k in 2016 to $9.8M currently. That's a -64.89% change in annual revenue.
Albireo Pharma annual revenue
Albireo Pharma annual revenue over time
| Fiscal year / year | Albireo Pharma revenue |
|---|---|
| 2016 | $28.0M |
| 2018 | $237,000 |
| 2019 | $1.4M |
| 2020 | $2.1M |
| 2021 | $3.7M |
| 2022 | $9.8M |
How accurately did Albireo Pharma's revenue projections match actual performance?
Albireo Pharma annual growth
Albireo Pharma saw the greatest revenue growth in 2018, when revenue increased by 746.43%.
Albireo Pharma had the lowest revenue growth in 2020, when revenue changed by 53.86%.
Albireo Pharma annual growth rate over time
| Year | Albireo Pharma growth |
|---|---|
| 2018 | -99%↓ |
| 2019 | 484%↑ |
| 2020 | 54%↑ |
| 2021 | 72%↑ |
| 2022 | 168%↑ |
Albireo Pharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Albireo Pharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | $570,000 | $1.3M | ($1.8M) |
| 2020 | $1.9M | $1.5M | $1.9M | ($3.5M) |
| 2021 | $2.4M | $2.0M | $2.4M | ($4.4M) |
| 2022 | $8.2M | $6.8M | $8.2M | ($15.0M) |
Albireo Pharma jobs nearby
Do you work at Albireo Pharma?
Is Albireo Pharma transparent about its revenue structure?
Albireo Pharma financial information
| CEO | Ronald H. W. Cooper |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 130 |
| Date Founded | 2008 |
| Headquarters | Boston, Massachusetts |
| Number of Locations | 2 |
| Revenue | $9.8M |
| Net Income | -$37,800,000 |
| Gross Proft | $9.2M (2022) |
| Tax Rate | -0.1% |
| Total Assets | $321,222,000 |
| Ticker | ALBO |
Albireo Pharma jobs you might like
Albireo Pharma financing
Albireo Pharma received early financing of $40.0M on 2008-02-01.
| Series | Round size | Date |
|---|---|---|
| Series A - Albireo | $40M | 02/2008 |
Albireo Pharma investors
| Investors | Security type |
|---|---|
| TVM Capital | Series A - Albireo |
| TPG Growth | Series A - Albireo |
Albireo Pharma competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Dynavax Technologies | - | $277.2M | 311 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Corvus Pharmaceuticals | - | $1.0M | 49 | - |
| Oncternal Therapeutics | - | $785,000 | 13 | - |
| Onconova Therapeutics | - | $226,000 | 12 | - |
| RedHill Biopharma | - | $64.4M | 100 | - |
| Akebia Therapeutics | - | $160.2M | 324 | - |
| Satsuma Pharmaceuticals | - | $492.9M | 5 | - |
| Ritter Pharmaceuticals | - | - | 5 | - |
| Crinetics Pharmaceuticals | - | $1.0M | 50 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Albireo Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Albireo Pharma. The employee data is based on information from people who have self-reported their past or current employments at Albireo Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Albireo Pharma. The data presented on this page does not represent the view of Albireo Pharma and its employees or that of Zippia.
Albireo Pharma may also be known as or be related to ALBIREO PHARMA INC., Albireo, Albireo Pharma, Albireo Pharma Inc and Albireo Pharma, Inc.